Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy). [electronic resource]
Producer: 20050915Description: 500-5 p. digitalISSN:- 0002-9149
- Abciximab
- Angina, Unstable -- blood
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents, Phytogenic -- pharmacology
- Coated Materials, Biocompatible
- Coronary Angiography
- Coronary Restenosis -- prevention & control
- Creatine Kinase -- blood
- Creatine Kinase, MB Form
- Double-Blind Method
- Drug Interactions
- Eptifibatide
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Isoenzymes -- blood
- Male
- Middle Aged
- Myocardial Ischemia -- diagnostic imaging
- Myocardial Revascularization -- instrumentation
- Paclitaxel -- pharmacology
- Peptides -- therapeutic use
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Stents
- Tirofiban
- Treatment Outcome
- Tyrosine -- analogs & derivatives
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.